π¬Deep Research
DNTH β Dianthus Therapeutics Inc Β· catalysts, narrative & risks
Dianthus Therapeutics (NASDAQ: DNTH) β Point-in-Time Profile (as of 2026-10-25)
Below is a synthesis of the company's recent activity, the competing bull/bear cases, key risks, and scheduled events. I draw primarily on company press releases and secondary reporting; where sources conflict or repeat one another, I flag this below.
Recent Catalysts (roughly JulyβOctober 2026)
AI-assisted research from the K3vl4r desk β not personalized investment advice. More research β